IISc Researchers Discover Antibiotic Combo to Combat TB Drug Resistance
What Happened?
Researchers at the Indian Institute of Science have found that combining isoniazid with vancomycin can reverse drug resistance in tuberculosis, showing promising results in lab tests and mice.
Key points
- The study published in Microbiology Spectrum identifies a combination of isoniazid and vancomycin.
- This combination significantly reduced bacterial growth in drug-resistant TB patients' samples.
- In mice, the combination reduced bacterial load by about 10-fold after 10 days of treatment.
- The study's authors include Nagasuma Chandra, Amit Singh, and Sukriti Pal.
- The combination is not yet ready for clinical use and requires further safety studies.
Key insights
- The combination therapy may significantly improve treatment outcomes for patients with drug-resistant TB.
- If successful in clinical trials, this approach could change the standard treatment for TB.
- The research highlights the ongoing challenge of antibiotic resistance in infectious diseases.
Why it matters
This discovery could lead to new treatment strategies for drug-resistant tuberculosis, a major global health issue.
Entities
Source
Times of India

